BeOne Medicines Ltd. (ONC) investor relations documents from the company's IR site: 2 presentations, 1 press release; latest deck 2026-08-05. Read in-app with summaries. First-party data.
Investor Presentation – Q2 2026: BeOne reported Q2 2026 revenue of $1.7 billion, a 30% increase year-over-year, and raised its full-year 2026 revenue guidance to $6.6–$6.8 billion.
| Published | Type | Document |
|---|---|---|
| 2026-08-04 | Press release | Earnings Release |
| 2026-08-05 | Quarterly report | Q2 2026 Clinical Trials Portfolio |
| 2026-08-05 | Presentation | Investor Presentation – Q2 2026 |
| 2026-06-01 | Presentation | ASCO 2026 Investor Event Presentation |
ONC overview · ONC earnings · ONC financials · ONC KPIs · ONC documents · ONC ownership · ONC peers
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.